Garrison Point Advisors, LLC Acadia Pharmaceuticals Inc Transaction History

Garrison Point Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	SELL	$17.8 - $25.65 $4,450 - $6,412	-250 Reduced 2.43%	10,020 $239,000
Q2 2022 Aug 10, 2022	BUY	$13.01 - $27.22 $650 - $1,361	50 Added 0.49%	10,270 $145,000
Q4 2021 Feb 14, 2022	BUY	$16.79 - $27.09 $171,593 - $276,859	10,220 New	10,220 $239,000
Q1 2021 May 04, 2021	SELL	$25.02 - $54.99 $113,215 - $248,829	-4,525 Closed	0 $0
Q4 2020 Jan 28, 2021	BUY	$41.04 - $56.79 $185,706 - $256,974	4,525 New	4,525 $242,000
Q3 2020 Oct 27, 2020	SELL	$36.42 - $57.0 $164,800 - $257,925	-4,525 Closed	0 $0
Q2 2020 Aug 03, 2020	SELL	$39.26 - $52.73 $9,815 - $13,182	-250 Reduced 5.24%	4,525 $219,000
Q1 2020 Apr 20, 2020	SELL	$31.65 - $46.87 $42,790 - $63,368	-1,352 Reduced 22.07%	4,775 $202,000
Q3 2019 Nov 12, 2019	BUY	$22.22 - $44.01 $136,141 - $269,649	6,127 New	6,127 $221,000

288

161M

723K

257K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.38B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Garrison Point Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Garrison Point Advisors, LLC with notifications on news.